Autonomic Technologies, Inc. , a Redwood City, CA-based developer and manufacturer of Pulsante™, a microstimulator to treat severe headaches, raised an additional $5.5M and closed a Series D round of financing at $43.2M.
The investment was made by HBM Healthcare Investments
LTD. The round was led by Edmond de Rothschild Investment Partners (EdRIP), the Paris based venture capital firm, syndicated with Forbion Capital Partners, from Naarden, the Netherlands. Existing investors Kleiner Perkins Caufield and Byers, InterWest Partners, Aberdare Ventures, Novatis Venture Funds, and Cleveland Clinic also invested.
ATI has started commercialization of the Pulsante microstimulator in Europe and has also established Autonomic Technologies Europe GmbH, a wholly owned subsidiary in Germany, to further expand European commercialization. The Pulsante® SPG Microstimulator System is under an IDE study in the US for the treatment of chronic cluster headache. The company will use proceeds from the financing to fund the ongoing IDE study in the USA.